Stryker Corp. (SYK): Price and Financial Metrics

Stryker Corp. (SYK): $285.28

0.83 (+0.29%)

POWR Rating

Component Grades








SYK Price/Volume Stats

Current price $285.28 52-week high $306.93
Prev. close $284.45 52-week low $200.80
Day low $283.40 Volume 953,373
Day high $287.73 Avg. volume 1,290,618
50-day MA $286.34 Dividend yield 1.02%
200-day MA $277.20 Market Cap 108.34B

SYK Stock Price Chart Interactive Chart >


  • Sentiment is the dimension where SYK ranks best; there it ranks ahead of 89.22% of US stocks.
  • The strongest trend for SYK is in Growth, which has been heading down over the past 179 days.
  • SYK's current lowest rank is in the Momentum metric (where it is better than 21.33% of US stocks).

SYK Stock Summary

  • With a market capitalization of $111,358,586,968, STRYKER CORP has a greater market value than 98.09% of US stocks.
  • SYK's went public 35.66 years ago, making it older than 89.84% of listed US stocks we're tracking.
  • Price to trailing twelve month operating cash flow for SYK is currently 36.81, higher than 89.27% of US stocks with positive operating cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to STRYKER CORP are GE, ETN, ZTS, IBM, and HON.
  • SYK's SEC filings can be seen here. And to visit STRYKER CORP's official web site, go to

SYK Valuation Summary

  • In comparison to the median Healthcare stock, SYK's EV/EBIT ratio is 214.52% higher, now standing at 39.
  • Over the past 243 months, SYK's price/sales ratio has gone up 1.1.

Below are key valuation metrics over time for SYK.

Stock Date P/S P/B P/E EV/EBIT
SYK 2023-09-18 5.7 6.4 41.1 39.0
SYK 2023-09-15 5.7 6.4 41.0 38.9
SYK 2023-09-14 5.8 6.5 41.4 39.2
SYK 2023-09-13 5.8 6.5 41.7 39.4
SYK 2023-09-12 5.8 6.4 41.3 39.1
SYK 2023-09-11 5.9 6.6 42.0 39.7

SYK Growth Metrics

    Its year over year revenue growth rate is now at 18.44%.
  • Its 2 year cash and equivalents growth rate is now at -63.22%.
  • Its 2 year net cashflow from operations growth rate is now at 22.07%.
SYK's revenue has moved up $1,780,000,000 over the prior 15 months.

The table below shows SYK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 18,449 2,624 2,358
2022-09-30 17,948 2,621 2,457
2022-06-30 17,629 2,665 2,079
2022-03-31 17,430 3,014 2,015
2021-12-31 17,108 3,263 1,994
2021-09-30 16,669 3,500 1,900

SYK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SYK has a Quality Grade of C, ranking ahead of 70.62% of graded US stocks.
  • SYK's asset turnover comes in at 0.492 -- ranking 96th of 186 Medical Equipment stocks.
  • ISRG, ABMD, and BSX are the stocks whose asset turnover ratios are most correlated with SYK.

The table below shows SYK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.492 0.638 0.100
2021-06-30 0.486 0.644 0.114
2021-03-31 0.447 0.628 0.081
2020-12-31 0.450 0.631 0.096
2020-09-30 0.461 0.636 0.113
2020-06-30 0.478 0.633 0.108

SYK Price Target

For more insight on analysts targets of SYK, see our SYK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $287.72 Average Broker Recommendation 1.6 (Moderate Buy)

Stryker Corp. (SYK) Company Bio

Stryker Corporation is an American multinational medical technologies corporation based in KalamazooMichigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. (Source:Wikipedia)

SYK Latest News Stream

Event/Time News Detail
Loading, please wait...

SYK Latest Social Stream

Loading social stream, please wait...

View Full SYK Social Stream

Latest SYK News From Around the Web

Below are the latest news stories about STRYKER CORP that investors may wish to consider to help them evaluate SYK as an investment opportunity.

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

KALAMAZOO, Mich., September 19, 2023--Stryker launched its PROstep® MIS Lapidus, a new minimally invasive surgical option for treating patients with bunions.

Yahoo | September 19, 2023

If You Invested $1000 in Stryker a Decade Ago, This is How Much It'd Be Worth Now

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Yahoo | September 19, 2023

The Zacks Analyst Blog Highlights NVIDIA, Advanced Micro Devices, Stryker, Canadian National Railway and Target

NVIDIA, Advanced Micro Devices, Stryker, Canadian National Railway and Target are part of the Zacks top Analyst Blog.

Yahoo | September 19, 2023

Top Research Reports for NVIDIA, AMD, Stryker & Others

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Advanced Micro Devices, Inc. (AMD) and Stryker Corporation (SYK).

Yahoo | September 18, 2023

Stryker's (SYK) New Camera Platform to Improve Surgery Outcomes

Stryker's (SYK) latest camera platform is likely to enhance the surgical experience across specialties.

Yahoo | September 15, 2023

Read More 'SYK' Stories Here

SYK Price Returns

1-mo 3.38%
3-mo -3.99%
6-mo 3.64%
1-year 38.18%
3-year 45.00%
5-year 72.98%
YTD 17.29%
2022 -7.42%
2021 10.22%
2020 18.17%
2019 35.33%
2018 2.43%

SYK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full SYK Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!